 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 July 1999 | Volume 131 Issue 1 | Pages 27-31
Background: Impaired ability to eliminate lipids in the postprandial state is an atherogenic trait associated with insulin resistance.
Objective: To assess insulin sensitivity and postprandial triglyceride metabolism in prediabetic persons.
Design: Cross-sectional study.
Setting: Sahlgrenska University Hospital, Göteborg, Sweden.
Participants: 13 healthy, normotriglyceridemic men with two first-degree relatives with type 2 diabetes and 13 carefully matched controls without known diabetes heredity.
Measurements: Oral glucose tolerance test, insulin sensitivity (euglycemic clamp technique), and fasting and postprandial triglyceride levels after a mixed meal.
Results: Relatives of persons with type 2 diabetes were insulin resistant but had normal glucose tolerance. They exhibited postprandial hypertriglyceridemia; the 6-hour triglyceride incremental area under the curve was 50% higher than that of the control group (P = 0.037).
Conclusions: These healthy male first-degree relatives of patients with type 2 diabetes are insulin resistant and exhibit postprandial lipid intolerance despite having normal fasting triglyceride levels. These characteristics, which occur in the absence of glucose intolerance, are associated with an increased risk for macroangiopathy.
Author and Article Information
From the Lundberg Laboratory for Diabetes Research, Sahlgrenska University Hospital, Göteborg University, Göteborg, Sweden; Norrland University Hospital, Umeå, Sweden; and the University of Helsinki, Helsinki, Finland.
Acknowledgment: The authors thank Ms. Margareta Landén for technical assistance.
Grant Support: By the Swedish Medical Research Council (project B-3506), the IngaBritt and Arne Lundberg Foundation, the Swedish Diabetes Association, the European Community (BMH4-CT96-0751), the Å ke Wiberg Foundation, the Magnus Bergvall Foundation, and the Regional Health Care Authority of West Sweden.
Requests for Reprints: Mette Axelsen, PhD, The Lundberg Laboratory for Diabetes Research, Department of Internal Medicine, Sahlgrenska University Hospital/SS, S-413 45 Göteborg, Sweden.
Current Author Addresses: Drs. Axelsen, Smith, and Jansson: The Lundberg Laboratory for Diabetes Research, Department of Internal Medicine, Sahlgrenska University Hospital/SS, S-413 45 Göteborg, Sweden.
Dr. Eriksson: Department of Medicine, Norrland University Hospital, S-901 85 Umeå, Sweden.
Dr. Taskinen: Department of Medicine, University Central Hospital, 002 90 Helsinki 29, Finland. BRIEF COMMUNICATION
Postprandial Hypertriglyceridemia and Insulin Resistance in Normoglycemic First-Degree Relatives of Patients with Type 2 Diabetes
This article has been cited by other articles:
|
|
 |
|
  P. Brassard, F. Frisch, F. Lavoie, D. Cyr, A. Bourbonnais, S. C. Cunnane, B. W. Patterson, R. Drouin, J.-P. Baillargeon, and A. C. Carpentier Impaired Plasma Nonesterified Fatty Acid Tolerance Is an Early Defect in the Natural History of Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 837 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Carpentier, F. Frisch, P. Brassard, F. Lavoie, A. Bourbonnais, D. Cyr, R. Giguere, and J.-P. Baillargeon Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E693 - E701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K.R. Karlsson, M. Ahlsen, J. R. Zierath, H. Wallberg-Henriksson, and H. A. Koistinen Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients. Diabetes, May 1, 2006; 55(5): 1283 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Carpentier, F. Frisch, D. Cyr, P. Genereux, B. W. Patterson, R. Giguere, and J.-P. Baillargeon On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E849 - E856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. D. Oakes, P. Thalen, T. Hultstrand, S. Jacinto, G. Camejo, B. Wallin, and B. Ljung Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R938 - R946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Yu and H. N. Ginsberg Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue Circ. Res., May 27, 2005; 96(10): 1042 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Greenfield, K. Samaras, C. S. Hayward, D. J. Chisholm, and L. V. Campbell Beneficial Postprandial Effect of a Small Amount of Alcohol on Diabetes and Cardiovascular Risk Factors: Modification by Insulin Resistance J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 661 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Annuzzi, C. De Natale, C. Iovine, L. Patti, L. Di Marino, S. Coppola, S. Del Prato, G. Riccardi, and A. A. Rivellese Insulin Resistance Is Independently Associated With Postprandial Alterations of Triglyceride-Rich Lipoproteins in Type 2 Diabetes Mellitus Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2397 - 2402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Abrass Overview: Obesity: What Does It Have to Do with Kidney Disease? J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2768 - 2772. [Full Text] [PDF]
|
|
|
|
|
|
H. Storgaard, C. B. Jensen, M. Bjornholm, X. M. Song, S. Madsbad, J. R. Zierath, and A. A. Vaag Dissociation between Fat-Induced in Vivo Insulin Resistance and Proximal Insulin Signaling in Skeletal Muscle in Men at Risk for Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1301 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Johanson, P.-A. Jansson, L. Lonn, Y. Matsuzawa, T. Funahashi, M.-R. Taskinen, U. Smith, and M. Axelsen Fat Distribution, Lipid Accumulation in the Liver, and Exercise Capacity Do Not Explain the Insulin Resistance in Healthy Males with a Family History for Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4232 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-A. JANSSON, F. PELLME, A. HAMMARSTEDT, M. SANDQVIST, H. BREKKE, K. CAIDAHL, M. FORSBERG, R. VOLKMANN, E. CARVALHO, T. FUNAHASHI, et al. A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin FASEB J, August 1, 2003; 17(11): 1434 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pellme, U. Smith, T. Funahashi, Y. Matsuzawa, H. Brekke, O. Wiklund, M.-R. Taskinen, and P.-A. Jansson Circulating Adiponectin Levels Are Reduced in Nonobese but Insulin-Resistant First-Degree Relatives of Type 2 Diabetic Patients Diabetes, May 1, 2003; 52(5): 1182 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pratipanawatr, K. Cusi, P. Ngo, W. Pratipanawatr, L. J. Mandarino, and R. A. DeFronzo Normalization of Plasma Glucose Concentration by Insulin Therapy Improves Insulin-Stimulated Glycogen Synthesis in Type 2 Diabetes Diabetes, February 1, 2002; 51(2): 462 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Inzucchi Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review JAMA, January 16, 2002; 287(3): 360 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Pratipanawatr, T. Pratipanawatr, K. Cusi, R. Berria, J. M. Adams, C. P. Jenkinson, K. Maezono, R. A. DeFronzo, and L. J. Mandarino Skeletal Muscle Insulin Resistance in Normoglycemic Subjects With a Strong Family History of Type 2 Diabetes Is Associated With Decreased Insulin-Stimulated Insulin Receptor Substrate-1 Tyrosine Phosphorylation Diabetes, November 1, 2001; 50(11): 2572 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Sandqvist, J. W. Eriksson, and P.-A. E. Jansson Increased Lactate Release per Fat Cell in Normoglycemic First-Degree Relatives of Individuals With Type 2 Diabetes Diabetes, October 1, 2001; 50(10): 2344 - 2348. [Abstract] [Full Text]
|
|
Article
